2LB Phase III, randomized, open-label, parallel-group study...

2LB Phase III, randomized, open-label, parallel-group study of oral gefitinib (IRESSA) versus intravenous docetaxel in patients with locally advanced or metastatic non-small-cell lung cancer who have previously received platinum- based chemotherapy (INTEREST)

J.Y. Douillard, E.S. Kim, V. Hirsh, T. Mok, M. Socinski, R. Gervais, L.Y. Wu, L. Li, M. Sellers, E. Lowe
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
5
Year:
2007
Language:
english
DOI:
10.1016/s1359-6349(07)70095-2
File:
PDF, 39 KB
english, 2007
Conversion to is in progress
Conversion to is failed